The European Commission has announced a new plan, called 'AccelerateEU', aimed at protecting citizens and the European economy from the volatility of energy prices, in the context of recent geopolitical tensions. Since the escalation of the conflict in the Middle East, the EU has spent an additional 24 billion euros on energy imports. Ursula von der Leyen, the President of the Commission, emphasized that accelerating the transition to clean energy is essential for energy security. The plan includes short-term measures, such as coordinating gas and oil stocks, establishing a Fuel Observatory, energy vouchers for vulnerable households, and a temporary framework for state aid. Additionally, the electrification and modernization of energy networks will be accelerated, with the aim of mobilizing significant investments, estimating a need of approximately 660 billion euros annually until 2030. The proposals will be discussed by European leaders at the meeting in Cyprus, scheduled for April 23-24.
Sources
UE prezintă un plan pentru criza energetică / Proiectul „AccelerateEU” promite sprijin rapid și investiții masive în energie curată
AccelerateEU: Comisia Europeană propune măsuri pentru a reduce impactul șocurilor energetice externe și a accelera tranziția verde - caleaeuropeana.ro
„AccelerateEU", planul european pentru combaterea crizei energetice. Se pune la punct „Observatorul combustibililor”
Latest News
16:09
An outbreak of sheep pox has been confirmed on a farm with hundreds of sheep in Iași
15:57
Tourists in the Danube Delta are showing concern about the RO-Alert messages, while accommodation unit owners are reporting cancellations of reservations.
15:54
An analysis by the European Policy Centre calls for the new Arctic strategy of the EU to include security and the risks of a possible Russian attack.
15:50
Italy will propose to EU member states the establishment of centers for migrants outside the community bloc.
15:50
Veterinarians in the European Union will have to justify more strictly the use of certain antibiotics outside of authorized indications.
See more news